US Stock Market Move | Tesla, Inc. (TSLA.US) rises over 4%, generously investing $20 billion in AI and the Siasun Robot & Automation track.
On Friday, Tesla (TSLA.US) rose more than 4%, reaching $433.94.
On Friday, Tesla, Inc. (TSLA.US) rose over 4% to $433.94. It is reported that the automotive business is stagnant, and Musk is betting the future of the company on AI and Siasun Robot & Automation technology, transitioning Tesla, Inc. from a hardware company to a physical AI company. Musk stated that the Model S and Model X factory in Fremont, California will be converted into the production base for the upcoming Optimus Siasun Robot & Automation by Tesla, Inc. According to official statements from Tesla, Inc. and Musk, the Optimus Siasun Robot & Automation is set to begin production by the end of 2026 and be available to the public in 2027.
Tesla, Inc.'s CFO Vaibhav Taneja mentioned that the company's capital expenditure for this year is around $20 billion, with investments focused on new factories, Optimus Siasun Robot & Automation, and AI computational resources. Recently, Tesla, Inc. reached an agreement with Musk's AI startup company xAI to invest about $2 billion.
Tesla, Inc. stated that the investment in xAI and partnership with the company is aimed at enhancing Tesla, Inc.'s ability to develop and deploy AI products and services on a large scale in the real world.
Related Articles

New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?
New Stock Preview | From "Deep Squatting" in Performance to Global Leapfrogging: Decoding the Breakthrough Logic of Sirio Pharma (300791.SZ)

From the sharp decline in the entrance to the "doji star", is the reversal of the low-stage consolidation of INNOGEN-B (02591) imminent?

New stock preview | Hujia Technology: Dual pressure of single brand and online dependence Can high-tech profit margins continue?

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


